Dr. Robert Figlin is a specialist in medical oncology based in Los Angeles, California and he is affiliated with many regional hospitals, like Cedars-Sinai Medical Center and UCLA Medical Center. He graduated from Medical College of Pennsylvania where he got his medical degree. He did his residency program in internal medicine at Cedars-Sinai Medical Center. He did a fellowship in hematology at UCLA Medical Center. The doctor is board certified in internal medicine and medical oncology and he has been practicing for more than 20 years.
Medical College of Pennsylvania
Cedars-Sinai Medical Center
UCLA Medical Center
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
The value of surrogate endpoints for predicting real-world survival across five cancer types.
Shafrin, J.,Brookmeyer, R.,Peneva, D.,Park, J.,Zhang, J.,Figlin, R. A.,Lakdawalla, D. N.; Curr Med Res Opin. 2016 Jan 09.See more >>
Clinical and Translational Assessment of VEGFR1 as a Mediator of the Premetastatic Niche in High-Risk Localized Prostate Cancer.
Pal, S. K.,Vuong, W.,Zhang, W.,Deng, J.,Liu, X.,Carmichael, C.,Ruel, N.,Pinnamaneni, M.,Twardowski, P.,Lau, C.,Yu, H.,Figlin, R. A.,Agarwal, N.,Jones, J. O.; Mol. Cancer Ther.. 2015 Oct 10.See more >>
The High-Dose Aldesleukin "Select" Trial: A Trial to Prospectively Validate Predictive Models of Response Treatment in Patients with Metastatic Renal Cell Carcinoma.
McDermott, D. F.,Cheng, S. C.,Signoretti, S.,Margolin, K. A.,Clark, J. I.,Sosman, J. A.,Dutcher, J. P.,Logan, T. F.,Curti, B. D.,Ernstoff, M. S.,Appleman, L.,Wong, M. ...; Clin. Cancer Res.. 2014 Nov 27.See more >>
American Society of Clinical Oncology